Approved on April 30, 2021
Pfizer, Inc.
This document was produced by the Food and Drug Administration (FDA) in response to a Freedom of Information Act (FOIA) request (see https://phmpt.org/wp-content/uploads/2021/10/001-Complaint-101021.pdf). The request was submitted by Public Health and Medical Professionals for Transparency.
Appendix 1 (pp. 30-38) lists more than 1,200 "adverse events of special interest" identified in the report period (ending February 28, 2021).
Acquired via FOIA request by Public Health and Medical Professionals for Transparency.
document
adverse events,clinical trials,COVID-19,manufacturers,vaccines